Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Leukemia

  Free Subscription


12.07.2021

2 Ann Hematol
1 BMC Cancer
6 Bone Marrow Transplant
1 Cancer Lett
1 J Clin Oncol
1 J Pediatr Hematol Oncol
1 J Virol
1 Leuk Res
1 Oncogene
1 PLoS One
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Hematol

  1. BARZEGAR M, Farsani MA, Rafiee M, Amiri V, et al
    Acute promyelocytic leukemia derived extracellular vesicles conserve PML-RARalpha transcript from storage-inflicted degradation: a stable diagnosis tool in APL patients.
    Ann Hematol. 2021 Jul 8. pii: 10.1007/s00277-021-04579.
    PubMed         Abstract available

  2. TANIGAWA T, Sakurai M, Kato J, Mizuno K, et al
    Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation.
    Ann Hematol. 2021 Jul 8. pii: 10.1007/s00277-021-04586.
    PubMed        


    BMC Cancer

  3. WANG B, Yang B, Wu W, Liu X, et al
    The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia.
    BMC Cancer. 2021;21:788.
    PubMed         Abstract available


    Bone Marrow Transplant

  4. LOKE J, Labopin M, Craddock C, Niederwieser D, et al
    Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.
    Bone Marrow Transplant. 2020 Oct 2. pii: 10.1038/s41409-020-01072.
    PubMed         Abstract available

  5. JENTZSCH M, Grimm J, Bill M, Brauer D, et al
    ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 19. pii: 10.1038/s41409-020-01129.
    PubMed         Abstract available

  6. QIAN CS, Ma X, Wang J, Wang TJ, et al
    PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation.
    Bone Marrow Transplant. 2021;56:1003-1005.
    PubMed        

  7. HUA J, Zhang J, Zhang X, Wu X, et al
    Donor-derived anti-CD19 CAR T cells compared with donor lymphocyte infusion for recurrent B-ALL after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2020 Nov 24. pii: 10.1038/s41409-020-01140.
    PubMed         Abstract available

  8. KANAAN SB, Delaney C, Milano F, Scaradavou A, et al
    Cord blood maternal microchimerism following unrelated cord blood transplantation.
    Bone Marrow Transplant. 2021;56:1090-1098.
    PubMed         Abstract available

  9. GREIL C, Engelhardt M, Ihorst G, Duque-Afonso J, et al
    Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia.
    Bone Marrow Transplant. 2021 Jul 8. pii: 10.1038/s41409-021-01366.
    PubMed        


    Cancer Lett

  10. LIU Q, Hua M, Zhang C, Wang R, et al
    NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1beta/Th1/IFN-gamma in acute myeloid leukemia.
    Cancer Lett. 2021 Jul 5. pii: S0304-3835(21)00299.
    PubMed         Abstract available


    J Clin Oncol

  11. VROOMAN LM, Blonquist TM, Stevenson KE, Supko JG, et al
    Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001.
    J Clin Oncol. 2021 Jul 6:JCO2003692. doi: 10.1200/JCO.20.03692.
    PubMed         Abstract available


    J Pediatr Hematol Oncol

  12. GURLEK GOKCEBAY D, Akcabelen YM, Yarali N, Ozbek NY, et al
    A Survey of Parents on the Effects of COVID-19 Pandemic on Children Receiving Antileukemic Therapy.
    J Pediatr Hematol Oncol. 2021;43:e740-e741.
    PubMed        


    J Virol

  13. ERBECK K, Gagne RB, Kraberger S, Chiu ES, et al
    Feline leukemia virus (FeLV) endogenous and exogenous recombination events result in multiple FeLV-B subtypes during natural infection.
    J Virol. 2021 Jul 7:JVI0035321. doi: 10.1128/JVI.00353.
    PubMed         Abstract available


    Leuk Res

  14. DEMINA I, Zerkalenkova E, Zhogov V, Lagoyko S, et al
    The use of additional immunophenotypic criteria for the differential diagnosis of Burkitt lymphoma/leukemia: An exemplary case report.
    Leuk Res. 2021;110:106662.
    PubMed        


    Oncogene

  15. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed         Abstract available


    PLoS One

  16. CATHERINET C, Passaro D, Gachet S, Medyouf H, et al
    NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0254184.
    PubMed         Abstract available


    Virology

  17. MURAKAMI H, Murakami-Kawai M, Kamisuki S, Hisanobu S, et al
    Specific antiviral effect of violaceoid E on bovine leukemia virus.
    Virology. 2021;562:1-8.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: